Cawachi Limited

2664

JP3226450009

Drug Retailers

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-14 am EDT			5-day change	1st Jan Change
2,797 ^JPY	-0.67%		-1.96%	+5.39%

Apr. 26	Cawachi Limited Provides Consolidated Earnings Guidance for the Six Months Ending September 2024 and Year Ending March 2025	CI
Jan. 30	Cawachi’s Attributable Profit Up 4.8% in Fiscal Nine Months on Marginal Growth in Sales	MT

Cawachi Limited Provides Consolidated Earnings Guidance for Year Ending March 15, 2023

January 27, 2023 at 01:00 am EST

Cawachi Limited provided consolidated earnings guidance for year ending March 15, 2023. For the period, the company expected net sales of JPY 280,000 million, operating profit of JPY 7,000 million, profit attributable to owners of parent of JPY 4,600 million, Basic earnings per share of JPY 205.96 per basic share.

Latest news about Cawachi Limited

Cawachi Limited Provides Consolidated Earnings Guidance for the Six Months Ending September 2024 and Year Ending March 2025	Apr. 26	CI
Cawachi’s Attributable Profit Up 4.8% in Fiscal Nine Months on Marginal Growth in Sales	Jan. 29	MT
Cawachi Limited Provides Consolidated Earnings Guidance for the Period Ending March 2024	Jan. 25	CI
Cawachi Limited Provides Earnings Guidance for the Quarter Ending March 31, 2024	23-10-26	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Full Year Ending March 2024	23-07-26	CI
Cawachi Limited Provides Earnings Guidance for the Interim Period Ended September 2023 and Full Year Ended March 2024	23-04-28	CI
Cawachi Limited Provides Consolidated Earnings Guidance for Year Ending March 15, 2023	23-01-27	CI
Cawachi Limited Provides Consolidated Earnings Guidance for Year Ending March 2023	22-10-26	CI
Cawachi Limited Provides Earnings Guidance for the Six Months Ending September 2022 and Year Ending March 15, 2023	22-07-28	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending March 15, 2023	22-05-20	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 15, 2023	22-04-27	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 15, 2022	22-01-27	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 15, 2022	21-10-27	CI
Cawachi Limited Announces Consolidated Earnings Results for the First Quarter Ended June 15, 2021	21-07-28	CI
Cawachi Limited Provides Earnings Guidance for the Six Months Ending September 15, 2021 and Year Ending March 15,2022	21-07-28	CI
Cawachi Limited Reports Consolidated and Non-Consolidated Earnings Results for the Fiscal Year Ended March 15, 2021	21-04-26	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2022	21-04-26	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021	21-01-22	CI
Cawachi Limited Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2020	21-01-22	CI
Cawachi Limited Announces Consolidated Earnings Results for the Second Quarter Ended September 30, 2020	20-10-23	CI
Cawachi Limited Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2021	20-10-23	CI
Cawachi Limited Announces Earnings Results for the First Quarter Ended June 30, 2020	20-07-22	CI
Cawachi Limited Provides Earnings Guidance for the Six Months Ending September 2020 and Year Ending March 31, 2021	20-07-22	CI
Cawachi Limited Announces Consolidated and Non- Consolidated Earnings Result for the Year Ended March 15, 2020; Provides Consolidated Earnings Guidance for the First Half and Fiscal Full Year Ending March 15, 2021	20-04-24	CI
Cawachi Limited Reports Consolidated Earnings Results for the Third Quarter Ended December 2019; Provides Consolidated Earnings Guidance for the Quarter Ending March 2020	20-01-24	CI

Chart Cawachi Limited

Duration

Period

More charts

Company Profile

CAWACHI LIMITED is a Japan-based company engaged in the operation of drugstores. The Company sells pharmaceutical products, including cold medicines, digestive medicines, various vitamin tablets, eye drops and nursing care items; cosmetics, including basic skin care products, makeup products and cosmetics for men; miscellaneous goods, including detergents, toilet papers, pet items and milk powders, as well as food products, including processed food products, dairy products, confectioneries, beverages and alcohol through its drugstores.

Sector

Drug Retailers

Calendar

2024-07-23 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
CAWACHI LIMITED	+5.39%	403M
COSMOS PHARMACEUTICAL CORPORATION	-13.23%	3.49B
SUNDRUG CO.,LTD.	-6.66%	3.17B
TSURUHA HOLDINGS INC.	-24.46%	3.13B
LBX PHARMACY CHAIN	+20.04%	2.9B
SUGI HOLDINGS CO.,LTD.	+11.77%	2.78B
KUSURI NO AOKI HOLDINGS CO., LTD.	-8.42%	1.78B
CREATE SD HOLDINGS CO., LTD.	+10.93%	1.4B
GREAT TREE PHARMACY CO., LTD.	-18.88%	984M
SHUYU CIVILIAN PHARMACY CORP., LTD.	-38.23%	707M

Retail - Drugs with Grocery

Cawachi Limited

Equities

2664

JP3226450009

Drug Retailers

Cawachi Limited Provides Consolidated Earnings Guidance for Year Ending March 15, 2023

Latest news about Cawachi Limited

Chart Cawachi Limited

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Retail - Drugs with Grocery